Expression and function of FRA2/JUND in cutaneous T-cell lymphomas

Anticancer Research

Volumn 32, Issue 4, 2012, Pages 1367-1373

  Nakayama, Takashi ^a   Higuchi, Tomonori ^a   Oiso, Naoki ^a   Kawada, Akira ^a   Yoshie, Osamu ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

BCL6; CCR4; Cutaneous T cell lymphoma; FRA2; JUND; MDM2; MYB

Indexed keywords

CHEMOKINE RECEPTOR CCR4; PROTEIN BCL 6; PROTEIN MDM2; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FRA 2; TRANSCRIPTION FACTOR JUND;

ADULT; AGED; ARTICLE; CELL GROWTH; CLINICAL ARTICLE; CUTANEOUS T CELL LYMPHOMA; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; LYMPHOMA CELL LINE; MALE; ONCOGENE MYB; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS ONCOGENE;

FEMALE; FOS-RELATED ANTIGEN-2; HUMANS; LYMPHOMA, T-CELL; MALE; PROTO-ONCOGENE PROTEINS C-JUN; SKIN NEOPLASMS;

EID: 84859951745     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Uchiyama T: Human T-cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol 15: 15-37, 1997.
2. Yoshie O, Fujisawa R, Nakayama T, Harasawa H, Tago H, Izawa D, Hieshima K, Tatsumi Y, Matsushima K, Hasegawa H, Kanamaru A, Kamihira S and Yamada Y: Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T-cells. Blood 99: 1505-1511, 2002. (Pubitemid 34533017)
3. Ishida T, Utsunomiya A, Iida S, Inagaki H, Takatsuka Y, Kusumoto S, Takeuchi G, Shimizu S, Ito M, Komatsu H, Wakita A, Eimoto T, Matsushima K and Ueda R: Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome. Clin Cancer Res 9: 3625-3634, 2003. (Pubitemid 37169227)
4. Nagakubo D, Jin Z, Hieshima K, Nakayama T, Shirakawa AK, Tanaka Y, Hasegawa H, Hayashi T, Tsukasaki K, Yamada Y and Yoshie O: Expression of CCR9 in HTLV-1+ T-cells and ATL cells expressing TAX. Int J Cancer 120: 1591-1597, 2007. (Pubitemid 46355398)
5. Yoshie O, Imai T and Nomiyama H: Chemokines in immunity. Adv Immunol 78: 57-110, 2001. (Pubitemid 32566018)
6. Nakayama T, Hieshima K, Arao T, Jin Z, Nagakubo D, Shirakawa AK, Yamada Y, Fujii M, Oiso N, Kawada A, Nishio K and Yoshie O: Aberrant expression of FRA2 promotes CCR4 expression and cell proliferation in adult T-cell leukemia. Oncogene 27: 3221-3232, 2008. (Pubitemid 351733385)
7. Shaulian E and Karin M: AP-1 as a regulator of cell life and death. Nat Cell Biol 4: E131-136, 2002. (Pubitemid 34521026)
8. Eferl R and Wagner EF: AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3: 859-868, 2003. (Pubitemid 37383716)
9. Kim EJ, Hess S, Richardson SK, Newton S, Showe LC, Benoit BM, Ubriani R, Vittorio CC, Junkins-Hopkins JM, Wysocka M and Rook AH: Immunopathogenesis and therapy of cutaneous T-cell lymphoma. J Clin Invest 115: 798-812, 2005. (Pubitemid 40489380)
10. Jones D, O'Hara C, Kraus MD, Perez-Atayde AR, Shahsafaei A, Wu L and Dorfman DM: Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma. Blood 96: 685-690, 2000. (Pubitemid 30463392)
11. Ferenczi K, Fuhlbrigge RC, Pinkus J, Pinkus GS and Kupper TS: Increased CCR4 expression in cutaneous T-cell lymphoma. J Invest Dermatol 119: 1405-1410, 2002. (Pubitemid 36005628)
12. Sokolowska-Wojdylo M, Wenzel J, Gaffal E, Lenz J, Speuser P, Erdmann S, Abuzahra F, Bowman E, Roszkiewicz J, Bieber T and Tuting T: Circulating clonal CLA(+) and CD4(+) T-cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7. Br J Dermatol 152: 258-264, 2005. (Pubitemid 40343595)
13. Poenitz N, Simon-Ackermann J, Gratchev A, Qadoumi M, Klemke CD, Stadler R, Kremer A, Radenhausen M, Henke U, Assaf C, Utikal J, Goerdt S and Dippel E: Overexpression of c-MYB in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma. Dermatology 211: 84-92, 2005. (Pubitemid 41160240)
14. Nakayama T, Watanabe Y, Oiso N, Higuchi T, Shigeta A, Mizuguchi N, Katou F, Hashimoto K, Kawada A and Yoshie O: Eotaxin-3/CC chemokine ligand 26 is a functional ligand for CX3CR1. J Immunol 185: 6472-6479, 2010.
15. Matsui M, Tokuhara M, Konuma Y, Nomura N and Ishizaki R: Isolation of human FOS-related genes and their expression during monocyte-macrophage differentiation. Oncogene 5: 249-255, 1990.
16. Nishina H, Sato H, Suzuki T, Sato M and Iba H: Isolation and characterization of FRA2, an additional member of the FOS gene family. Proc Natl Acad Sci USA 87: 3619-3623, 1990.
17. Kameda T, Akahori A, Sonobe MH, Suzuki T, Endo T and Iba H: JUND mutants with spontaneously acquired transforming potential have enhanced transactivating activity in combination with FRA2. Proc Natl Acad Sci USA 90: 9369-9373, 1993. (Pubitemid 23315785)
18. Milde-Langosch K, Roder H, Andritzky B, Asian B, Hemminger G, Brinkmann A, Bamberger CM, Loning T and Bamberger AM: The role of the AP-I transcription factors c-FOS, FOSB, FRA1 and FRA2 in the invasion process of mammary carcinomas. Breast Cancer Res Treat 86: 139-152, 2004. (Pubitemid 38988017)
19. Schroder C, Schumacher U, Muller V, Wirtz RM, Streichert T, Richter U, Wicklein D and Milde-Langosch K: The transcription factor FRA2 promotes mammary tumour progression by changing the adhesive properties of breast cancer cells. Eur J Cancer 46: 1650-1660, 2010.
20. Detry C, Lamour V, Castronovo V and Bellahcene A: CREB-1 and AP-1 transcription factors JUND and FRA2 regulate bone sialoprotein gene expression in human breast cancer cells. Bone 42: 422-431, 2008.
21. Ramsay RG and Gonda TJ: MYB function in normal and cancer cells. Nat Rev Cancer 8: 523-534, 2008. (Pubitemid 351881853)
22. Qin JZ, Zhang CL, Kamarashev J, Dummer R, Burg G and Dobbeling U: Interleukin-7 and interleukin-15 regulate the expression of the BCL2 and c-MYB genes in cutaneous T-cell lymphoma cells. Blood 98: 2778-2783, 2001.
23. Vargas DA, Takahashi S and Ronai Z: MDM2: A regulator of cell growth and death. Adv Cancer Res 89: 1-34, 2003. (Pubitemid 41184278)
24. McGregor JM, Crook T, Fraser-Andrews EA, Rozycka M, Crossland S, Brooks L and Whittaker SJ: Spectrum of p53 gene mutations suggests a possible role for ultraviolet radiation in the pathogenesis of advanced cutaneous lymphomas. J Invest Dermatol 112: 317-321, 1999. (Pubitemid 29125107)
25. Kallinich T, Muche JM, Qin S, Sterry W, Audring H and Kroczek RA: Chemokine receptor expression on neoplastic and reactive T-cells in the skin at different stages of mycosis fungoides. J Invest Dermatol 121: 1045-1052, 2003. (Pubitemid 37430972)
26. Pasqualucci L, Bereschenko O, Niu H, Klein U, Basso K, Guglielmino R, Cattoretti G and Dalla-Favera R: Molecular pathogenesis of non-Hodgkin's lymphoma: the role of BCL6. Leuk Lymphoma 44(Suppl 3): S5-12, 2003.
27. Gaulard P and de Levai L: Follicular helper T-cells: implications in neoplastic hematopathology. Semin Diagn Pathol 28: 202-213, 2011.
28. Suzuki T, Okuno H, Yoshida T, Endo T, Nishina H and Iba H: Difference in transcriptional regulatory function between c-FOS and FRA2. Nucleic Acids Res 19: 5537-5542, 1991. (Pubitemid 21912952)
29. Yoshida T, Suzuki T, Sato H, Nishina H and Iba H: Analysis of FRA2 gene expression. Nucleic Acids Res 21: 2715-2721, 1993.
30. Sonobe MH, Yoshida T, Murakami M, Kameda T and Iba H: FRA2 promoter can respond to serum-stimulation through AP-1 complexes. Oncogene 10: 689-696, 1995.
31. Murakami M, Sonobe MH, Ui M, Kabuyama Y, Watanabe H, Wada T, Handa H and Iba H: Phosphorylation and high level expression of FRA2 in v-src transformed cells: a pathway of activation of endogenous AP-1. Oncogene 14: 2435-2444, 1997. (Pubitemid 27268162)
32. Murakami M, Ui M and Iba H: FRA2-positive autoregulatory loop triggered by mitogen-activated protein kinase (MAPK) and FRA2 phosphorylation sites by MAPK. Cell Growth Differ 10: 333-342, 1999. (Pubitemid 29242599)
33. Yamamoto K, Utsunomiya A, Tobinai K, Tsukasaki K, Uike N, Uozumi K, Yamaguchi K, Yamada Y, Hanada S, Tamura K, Nakamura S, Inagaki H, Ohshima K, Kiyoi H, Ishida T, Matsushima K, Akinaga S, Ogura M, Tomonaga M and Ueda R: Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. J Clin Oncol 28: 1591-1598, 2010.
34. Ishida T, Joh T, Uike N, Yamamoto K, Utsunomiya A, Yoshida S, Saburi Y, Miyamoto T, Takemoto S, Suzushima H, Tsukasaki K, Nosaka K, Fujiwara H, Ishitsuka K, Inagaki H, Ogura M, Akinaga S, Tomonaga M, Tobinai K and Ueda R: Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-cell Leukemia-Lymphoma: A Multicenter Phase II Study. J Clin Oncol in press, 2012.